Search

everythinglearnresearchcommunity

for

Search:↓

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Androgenetic alopecia (AGA) is a common, hereditary hair loss condition that can be slowed but not permanently reversed with available therapies.

AGD1's PH domain is essential for its role in root hair growth and polarity.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

AGA linked to inflammation, stress, fibrosis, and disturbed hair follicle stem cells.

Genetic marker rs12558842 strongly linked to male hair loss.

Balding men have harder scalps.

AGA is caused by genetics and androgens, treatable with finasteride and minoxidil.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Hair loss treatment caused more hair loss in a man.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

The conclusion is that more women in their forties are getting AGA and stress is linked to AGA in both men and women.

Panax ginseng extract may help prevent hair loss caused by DKK-1.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

Two specific genetic markers increase the risk of hair loss in Asian populations.

KF19418 promotes hair growth similarly to minoxidil but is not better in live mice.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

The Hair660™ light therapy device effectively and safely improves hair density in people with androgenetic alopecia.

HDMHG0401-10 treatment significantly improved hair count and was better than a placebo in reducing hair loss in men with hereditary hair loss, with no major side effects.

A new microneedle system effectively delivers a vasodilator to hair follicles, promoting hair growth better than current treatments.

AKR1C enzymes in scalp glands decrease with age, possibly affecting hair loss.

A new microneedle patch effectively treats hair loss by delivering growth factors to the skin.

Kenogen increases with hair loss in women.

There is no significant link between the MMP-1 rs1799750 polymorphism and androgenetic alopecia in the Indonesian population.